HemoShear Therapeutics, LLC

  • Founded: 2008
  • CEO: Jim Powers
  • Size of Facility: 11000 sq ft
  • Company Size: 25
  • Funding Source: Grants (e.g. SBIR, CRCF, CIT), Investor Funded
  • Development Stage: Pre-clinical

HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat children’s rare metabolic disorders. Their goal is to discover drugs that save the lives of children who are born with metabolic defects and are unable to sustain basic biochemical processes necessary for life. The company’s proprietary technology allows for recapitulation of diseases using tissue from livers of children born with genetic defects, interrogate the disrupted biochemical processes, explore drug intervention strategies, and select drug candidates that they believe have high probabilities of clinical success.